Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Patients with renal-cell carcinoma who undergo nephrectomy have no options for adjuvant therapy to reduce the risk of recurrence that have high levels of supporting evidence.In a double-blin...